Directly observed therapy (multiple letters) [16]

Lancet

Volumn 350, Issue 9078, 1997, Pages 666-667

  Chaulk, C P ^a   Iseman, M D ^a   Garner, P ^a   Volmink, J ^a  

^a Annie E Casey Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST EFFECTIVENESS ANALYSIS; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; TUBERCULOSIS; UNITED STATES; COST BENEFIT ANALYSIS; DRUG THERAPY; ECONOMICS; NOTE; STANDARD;

ANTITUBERCULAR AGENTS; COST-BENEFIT ANALYSIS; DRUG THERAPY; HUMANS; PATIENT COMPLIANCE; TUBERCULOSIS;

EID: 0031591762     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63360-0     Document Type: Letter

References (0)